ClexBio (also known as Nordovo Biosciences AS) is a biotech company creating solutions for tissue engineering and single-cell techniques by combining bio-fabrication approaches with its proprietary hydrogel technology CLEX. It develops Competitive Ligand Exchange X-Linking (CLEX) technology to manipulate delicate living cells at the micro-scale, a prerequisite for recreating functional biological tissue architectures in the lab. ClexBio engineers patient-specific tissue transplants for preclinical and clinical applications by combining bio-fabrication tools, bio-materials, and living human cells.